Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

Medications for PCOS don't seem to raise heart disease risk.

Dexamethasone-primed stem cell media shows promise in treating lupus by reducing symptoms and inflammation.

Early diagnosis and treatment of TPP can prevent complications.

Menopause influences skin conditions, and hormone therapy should be considered in treatment.

Psoriasis treatments range from topical creams to systemic medications with serious side effects, and while treatments can manage symptoms, there is no cure.

Hair loss needs more research for better treatments.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Some common medications can harm male fertility, but many effects can be reversed.

Current treatments for male pattern baldness include minoxidil and finasteride, with new options being developed.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Herbs might help with hair loss, but more research is needed to confirm their safety and effectiveness.

Pharmacists should interpret lab data and perform physical exams to improve patient care.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

The document concludes that more research is needed to better understand and treat scarring hair loss conditions.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Altered metabolism can help control seizures by changing brain signaling and energy use, suggesting new treatments for epilepsy.

A 19-year-old male with delayed puberty was successfully treated for a condition that prevents normal hormone production.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Androgens contribute to common male hair loss; more research needed for hair growth medication.

The conclusion is that effectively treating hair disorders is difficult due to the complex factors affecting hair growth and more research is needed to improve treatments.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.